Navigation Links
Aethlon Medical Announces Hemopurifier® and HER2osome™ Cancer Therapy Presentation at Exosomes and Microvesicles 2011
Date:10/5/2011

SAN DIEGO, Oct. 5, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that the Aethlon Hemopurifier® and HER2osome™ cancer therapy will be the subject of a presentation at the Exosomes and Microvesicles 2011 conference on October 17th.  The event is being held at the Wyndham Lake Buena Vista Resort located in Walt Disney World, Florida.  Dr. Annette Marleau, Director of Tumor Immunology at Aethlon Medical will give the presentation.  Both the Aethlon Hemopurifier® and HER2osome™ represent novel exosome-targeted strategies to improve cancer treatment outcomes.  Exosomes released by cancers have recently emerged to become therapeutic targets in cancer care, as they are implicated in cancer survival, growth, and metastasis.  Researchers have also identified that cancer-released exosomes assist tumors in evading the response of the immune system.  

(Photo:  http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b)

About HER2osome™HER2osome™ provides a therapeutic strategy to maximize the ability of the immune system and established drug therapies to combat HER2+ breast cancer, which is characterized by aggressive growth and poor prognosis resulting from the over-expression of HER2 protein.  HER2osome™ is a novel medical device, whose goal is to inhibit HER2+ breast cancer progression by reducing the circulatory presence of HER2 protein and tumor-secreted exosomes that contribute to the development and progression of breast cancer.  Research publications indicate that breast cancer exosomes suppress the immune response, stimulate angiogenesis, contribute to the spread of metastasis, and inhibit the therapeutic benefit of Herceptin® (trastuzumab), a leading monoclonal antibod
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Aethlon Medical to Present at the 2009 RedChip Small-Cap Investor Conference on June 16, 2009
2. Aethlon Medical Announces Presentation of Hepatitis-C (HCV) Clinical Data at 42nd Annual American Society of Nephrology (ASN) Conference
3. Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus
4. Aethlon Medical Discloses Live Webcast of Todays BIOCOM Presentation
5. Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs
6. Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program
7. Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference
8. Aethlon Medical Reestablishes Biodefense Programs
9. Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships
10. Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
11. Aethlon Medical Names Rod Kenley President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015 ... study Stationary Oxygen Concentrators Market Shares, Strategy, ... poised to achieve continuing growth as the aging population ... and other respiratory conditions where oxygen is able to ... manner. Portable devices have become affordable and support a ...
(Date:7/1/2015)... OncoSec Medical Inc. ("OncoSec") (Nasdaq: ONCS ), a company ... President Punit Dhillon will ring The Nasdaq Opening ... Stock Market at 9:30 am ET on July 7, 2015 ... .   "On behalf of all of ... open the Nasdaq to celebrate OncoSec,s listing on this leading ...
(Date:7/1/2015)... -- New exchange plan enrollees spent less on medications ... same time a year ago, according to the third ... Exchange Pulse™ report, released today. When compared ... new exchange plan enrollees who used at least one ... of 2015. However, when evaluating exchange plan medication trends ...
Breaking Medicine Technology:Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 3Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 4OncoSec Medical to Ring The Nasdaq Stock Market Opening Bell 2OncoSec Medical to Ring The Nasdaq Stock Market Opening Bell 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 2Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 5
... Pharmaceuticals, Inc. (NYSE: WPI ), a leading integrated ... release its third quarter 2011 financial results on Tuesday, November ... markets.  The Company will also host a conference call and ... to discuss its financial results and provide an update on ...
... RANCHO CORDOVA, Calif., Sept. 23, 2011 AMPAC Fine ... Corporation (Nasdaq®: APFC), announced that Terence "Terry" Vollrath has ... very pleased to have an accomplished leader like Terry ... Aslam Malik, President of AFC.   Vollrath, ...
Cached Medicine Technology:Watson to Host Conference Call and Webcast to Discuss Third Quarter 2011 Earnings 2AMPAC Fine Chemicals Names Terry Vollrath Vice President of Operations 2AMPAC Fine Chemicals Names Terry Vollrath Vice President of Operations 3
(Date:7/1/2015)... ... ... Did you know that infertility in men is more common than couples ... Center of Texas (AFCT) would like to talk about some natural ways to increase ... be a “woman’s issue,” male fertility factors can play a role in about 40% ...
(Date:7/1/2015)... Humble, TX (PRWEB) , ... July 01, 2015 , ... ... also another symptom found in a significant number of women: leg pain. Northeast Houston ... , Leg pain, a symptom of venous reflux disease, is underdiagnosed and often ...
(Date:7/1/2015)... ... July 01, 2015 , ... Trevor L. Williams, DMD ... Florida and continued at USF earning a Master’s degree in Microbiology. He graduated from ... of the American Dental Association, the Florida Dental Association and the Academy of General ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... software products, announced today that it has received trademark protection for its SensorInsight® ... detailed analysis of data from multiple sources providing an environment where users can ...
(Date:7/1/2015)... ... 01, 2015 , ... A Priority Setting Partnership put in ... list they hope will guide future mesothelioma research. Surviving Mesothelioma has just posted ... , More than 450 mesothelioma patients, caregivers, and healthcare professionals answer the ...
Breaking Medicine News(10 mins):Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:Trevor L. Williams, D.M.D. Joins Enlow & Vance Dental Partners in Tampa, Florida 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4Health News:New Report Identifies Top 10 Mesothelioma Research Priorities, According to Surviving Mesothelioma 2
... -- Patients in hospitals where nurses work long hours are ... researchers have found. In most U.S. hospitals, nurses work ... due to nationwide nursing shortages, the authors of the new ... of the compressed nature of the work week, the long ...
... LOS ANGELES (January 19, 2011) Following a competitive ... Research for the Department of Pediatrics, Children,s Hospital Los ... the hospital to become part of the Autism Treatment ... The ATN is supported by Autism Speaks, which ...
... humans, has no known cure or vaccine. But a new ... a family of small molecules which appear to bind to ... into human cells. The results are to be published ... now online. Previous studies have shown that small molecules ...
... scientists have discovered that cells lining the blood vessels ... cells from invading other tissues, a finding that could ... Elazer Edelman, professor in the MIT-Harvard Division of Health ... adjacent to a patient,s tumor could shrink a tumor ...
... conducted at the Oregon National Primate Research Center at Oregon ... contraceptives cause weight gain appears to be false. The results ... next month,s edition of the journal Human Reproduction . ... contraceptives and the possibility that they may cause weight gain ...
... WEDNESDAY, Jan. 19 (HealthDay News) -- Many U.S. transplant ... trying to develop new safeguards that would protect and ... one-third of transplant surgeons in the nation "overreacted" to ... contracted HIV after receiving organs from a single donor ...
Cached Medicine News:Health News:Nurses' Long Shifts May Put Hospital Patients at Risk: Study 2Health News:Children's Hospital Los Angeles joins Autism Treatment Network 2Health News:Small molecules may prevent ebola infection 2Health News:MIT scientists discover cancer-fighting role for cells 2Health News:MIT scientists discover cancer-fighting role for cells 3Health News:MIT scientists discover cancer-fighting role for cells 4Health News:Do birth control pills cause weight gain? New research says no 2
... extensive line of affordable, high-quality light guide ... light sources to provide optimal brightness during ... and durable design give you the flexibility ... efficiently. And each is fully-autoclavable so they ...
Used under fluoroscopy for initial location and positioning of the renal collecting system throughout a percutaneous nephrostomy. Supplied sterile in peel-open packages. Intended for one-time use....
The Linvatec 3mm and 5mm Universal Light Guides are autoclavable. They offer flexibility, superior light transmission, and universal fittings in a lightweight package....
ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...
Medicine Products: